Pliant Therapeutics, Inc.
PLRX
$1.07
-$0.01-0.93%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 64.32% | 52.59% | 54.47% | 22.48% | -19.62% |
| Total Depreciation and Amortization | -41.07% | -20.31% | -18.05% | -28.14% | -12.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.19% | -23.79% | -29.69% | -21.27% | -3.06% |
| Change in Net Operating Assets | -14.90% | 75.08% | -119.27% | -304.21% | -189.46% |
| Cash from Operations | 60.65% | 62.68% | 34.68% | 10.36% | -61.42% |
| Capital Expenditure | -- | 100.00% | 100.00% | 91.05% | 82.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.06% | -95.50% | -12.84% | 197.82% | 13.66% |
| Cash from Investing | -105.93% | -95.48% | -9.82% | 231.59% | 16.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -85.14% | -100.00% | -86.74% | -100.00% | -73.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -85.14% | -31,734.31% | -86.74% | -100.00% | -97.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -212.08% | -472.94% | 997.66% | 84.91% | -59.37% |